No
abstract available |
INTRODUCTION
Several established methods for the imaging of atherosclerosis (quantitative
coronary arteriography [QCA], carotid intima-medial thickness, magnetic
resonance imaging, and intravascular ultrasound [IVUS]) have been used
in clinical trials to determine whether defined therapeutic interventions
slow the rate of progression of plaque size or composition, or reduce
severity of luminal obstruction, and whether change in these measures
predicts in-trial or future cardiovascular (CV) events. The report by
Berry et al8 in this issue of Circulation, which compares simultaneously-obtained
QCA measures of luminal obstruction with IVUS measures of plaque and luminal
volume or percent plaque volume and their in-trial changes is a timely
comparison between IVUS and QCA. The present editorial comment addresses
the emerging evidence on the relative utility of measurements by these
2 techniques for use as surrogates for efficacy in clinical trials. [...]
|